The lifting of the curse on antisense -- "no antisense drug has ever been approved" (except for the treatment of an obscure eye disease many years ago, and I think that was by injection directly into the eye rather than systemically) -- can only be a good thing for OGXI.
antisense has arrived but the street still gives no respect to ISIS. All the negatives that have surrounded Kynarmo are still in the forefront with potential investors.
They need to get over it or miss out what I think will be some nice upward PPS movement
Over the next 2 years ISIS has several potential significant PPS drivers as its pipeline matures through P2B and some very $$$$big money deals are struck for these assets. EPS and within the biotech sector no need for cash thus dilution are still king with most investors.
Hi Mr. Ssssamsa, if you go to Isis on Yahoo Finance, there are several good articles on the arrival of ASO drugs…New York Times and Forbes. As you say, can only boost OGXI profile leading to 011 release